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Abstract
Nucleoredoxin is a redox sensitive protein recently shown to be involved in the
Wnt/β-catenin pathway through binding dishevelled. When Wnt is present, dishevelled
prevents a destruction complex from degrading β-catenin. This facilitates the
translocation of β-catenin into the nucleus where it binds to TCF-LEF to impart changes
in gene expression. This study used mouse F9 cells as a model to examine whether or not
nucleoredoxin is involved in augmenting the Wnt/β-catenin signaling required for
extraembryonic endoderm differentiation. It was found that nucleoredoxin and three
dishevelled isoforms were present in F9 cells. Furthermore, nucleoredoxin was found to
bind to dishevelled-2, and when cells were treated with an oxidizing agent this interaction
diminished. Lastly, when nucleoredoxin expression was knocked down, F9 cells
differentiated into extraembryonic endoderm. Together, the data would indicate that the
Wnt/β-catenin signaling pathway obligatory for extraembryonic endoderm differentiation
is redox regulated at the level of nucleoredoxin.
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Chapter 1

1 Introduction
1.1 Early mouse development
During early mouse embryonic development, the fertilized egg undergoes a series of
mitotic divisions leading to the development of the morula [1]. Cells of the morula give
rise to one of two blastocyst lineages: trophectoderm or inner cell mass (ICM). The
trophectoderm arises from the outer cells of the blastocyst and is responsible for the
development of the embryonic placenta. The inner cells of the blastocyst form the ICM,
which further differentiates into the epiblast, giving rise to the embryo proper, or to
primitive endoderm (PrE) [1, 2] (Fig 1.1).
PrE further differentiates to parietal and visceral endoderms (PE and VE), which form
the parietal and visceral yolk sacs, respectively. The cells of the PrE, PE and VE,
collectively known as extraembryonic endoderm (ExE), are important for embryonic
patterning as well as for providing nutrients and signaling molecules to the developing
embryo [1, 3]. This differentiation of the ICM first to PrE and then to PE and VE is one
of the earliest epithelial-to-mesenchymal transitions (EMT) in the developing mouse
embryo. EMTs are characterized by the loss of E-cadherin expression, which eliminates
stable junctions between the cells, and allows for the development of a morphological
state suitable for cellular migration [4]. Analysing EMTs can provide insight into
developmental processes as well as tumour progression and cancer metastasis.
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Figure 1.1 Specified cells of the inner cell mass of the blastocyst differentiate first to
primitive endoderm and then to parietal and visceral endoderm. In early mouse
embryonic development, the blastocyst gives rise to cells of the inner cell mass (ICM).
The ICM differentiates to either the epiblast, giving rise to the embryo proper, or to
primitive endoderm (PrE). PrE further differentiates to parietal and visceral endoderms
(PE and VE), which form the parietal and visceral yolk sacs, respectively (Image
modified from [5]).
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1.2 The mouse F9 teratocarinoma cell line
Studying EMTs, and in particular the transition to ExE, is difficult to study in vivo.
Fortunately, researchers have been able to utilize the mouse F9 teratocarinoma cell line as
a model to mimic this process in vitro [6, 7]. The F9 cell line was established by grafting
6-day old embryos into host testes of the mouse 129/Sv strain to produce teratomas [8].
Normally, these F9 teratocarcinoma cells undergo little differentiation, but when treated
with retinoic acid (RA), a vitamin A derivative, the cells are induced to form PrE [9].
RA acts through binding to RA receptors and retinoid X receptors, which act as a
heterodimer to efficiently bind RA-response elements in the promoter regions of target
genes and transduce the retinoid signal [10, 11]. F9 cells have proven to be an important
model for studying RA signaling as they express all known RA receptors. RA-responsive
genes in F9 cells are numerous and include, but are not limited to, Gata6, FoxA2 and
Wnt6 [11, 12]. When F9 cells are treated with low concentrations (10-7 M) of RA,
changes in gene expression and cell morphology lead to the compact cells transitioning to
a flat appearance as they move apart from one another, a scenario resembling PrE
formation. Cytokeratin A intermediate filaments are also assembled and these can be
detected using TROMA-1 (TROphectodermal Monoclonal Antibody) [13, 14]. RA
signaling is therefore an essential regulator in cell differentiation and proliferation [4, 10].
F9 cells can be further induced to differentiate from PrE to PE by the addition of
dibutyryl cyclic adenosine monophosphate (db-cAMP) to RA-treated cells. PE in the
developing mouse embryo is in contact with the maternal blood; therefore PE should
contain biological characteristics of vascular endothelial cells. Increasing the levels of
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cAMP in F9 cells causes morphological changes as well as an increase in the secretion of
tissue-type plasminogen activator and Thrombomodulin (TM), reminiscent of what
occurs in the PE of mouse embryos [7, 14]. Accordingly, treating cells with RA followed
by db-cAMP thus recapitulates the EMT of the ICM differentiating into ExE. In this
study, TROMA-1 will be used as a pan-ExE marker while TM will be used as a marker
exclusive to PE [13, 14].

1.3 Canonical Wnt/β-catenin signaling
Wnts are secreted glycoproteins that play numerous roles in vertebrate development
including cell proliferation, cell survival, and determining cell fate [15]. In addition to
development, Wnt pathways are also involved in cancers, neurodegenerative diseases, the
regulation of bone density, and osteoarthritis [15]. There are nineteen known Wnts in
vertebrates that signal through three pathways: canonical Wnt/β-catenin, planar cell
polarity (PCP) or Wnt/Ca2+ pathway. My research focuses on canonical Wnt signaling as
my lab reported several years ago that RA activates this specific pathway in F9 cells, and
as a result cells differentiate to form ExE [16].
In the canonical Wnt/β-catenin pathway, Wnt binds to one of several seventransmembrane Frizzled (Fzd) receptors, and to low-density lipoprotein-receptor related
protein (LRP) 5/6. The binding of Wnt to its receptor causes Dishevelled (Dvl) to be
recruited to the plasma membrane where it acts to inhibit a destruction complex
composed of casein kinase 1 (CK1), glycogen synthase kinase 3 beta (GSK-3β), Axin,
and the adenomatous polyposis coli tumour suppressor protein (APC). Disrupting this
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complex allows β-catenin to accumulate in the cytosol, followed by its subsequent
translocation into the nucleus where it binds to T-cell-factor lymphoid enhancer factor
(TCF-LEF) to induce the transcription of Wnt target genes [16]. The regulated activation
and repression of Wnt target genes, such as Snail1, cyclinD1 and c-Myc, allows for cell
proliferation and differentiation to PrE [17]. In the absence of Wnt, however, Dvl is not
recruited to the plasma membrane, and therefore cannot disrupt the destruction complex.
This results in cytoplasmic β-catenin being ubiquitinated by an E3 ubiquitin ligase and
targeted for proteasomal destruction (Fig 1.2).

1.4 Reactive Oxygen Species
Recently, our lab has found that the RA-induced activation of canonical Wnt
signaling in F9 cells and subsequent PrE formation is accompanied by increased reactive
oxygen species (ROS) levels [18]. Not surprisingly, while increasing β-catenin levels is
sufficient to induce PrE, it has been known for several years that other mechanisms are
necessary to maintain cells in this state [6]. ROS is a term used to describe various
species such as superoxides, hydrogen peroxide, and hydroxyl radicals. The most
common production of ROS are as by-products from the incomplete reduction of oxygen
through cellular respiration [19, 20]. More recent evidence shows ROS are also produced
through NADPH oxidases (Nox), a plasma membrane-coupled enzyme complex that
generates O2- using cytosolic NADPH as an electron donor [19].
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Figure 1.2 Canonical Wnt/β-catenin signaling in F9 cells induces differentiation to PrE.
Wnt binds to one of several Frizzled receptors, and to low-density lipoprotein-receptor
related protein 5/6. This interaction causes Dishevelled (Dvl) to be phosphorylated and
recruited to the plasma membrane where it acts to inhibit a destruction complex, thereby
allowing β-catenin to accumulate in the cytosol and subsequently translocate to the
nucleus where it binds to T-cell-factor lymphoid enhancer factor to induce the
transcription of Wnt target genes necessary for PrE differentiation. In the absence of Wnt,
Dvl is not recruited to the plasma membrane, and therefore it is unable to disrupt the
destruction complex. As a result, β-catenin is targeted for proteasomal destruction.
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ROS are known to have deleterious effects causing damage to nucleic acids, proteins
and lipids, however, antioxidants within the cell are able to regulate ROS levels to
minimize this damage [21-23]. Besides deleterious effects, convincing studies indicate
that cells use ROS in a beneficial manner to induce biological changes, including
differentiation, proliferation, and apoptosis [24]. In particular, one ROS, hydrogen
peroxide (H2O2) acts on the Wnt pathway to stimulate differentiation [25]. Our lab
recently reported that F9 cells treated with H2O2 show morphological and molecular
changes similar to that of RA treatment, causing cells to differentiate into PrE [18]
[Hwang and Kelly, unpublished]. Together the data indicate that ROS are involved in
crosstalk with the canonical Wnt/β-catenin pathway during ExE differentiation. The
desire to better understand how this crosstalk augments Wnt signaling forms the basis of
my thesis.

1.5 Nucleoredoxin and Dishevelled
Our lab has reported that when F9 cells are treated with RA to induce differentiation
to PrE, there is an accompanied increase in ROS levels [18]. Furthermore, in the absence
of RA, F9 cells treated with H2O2 differentiate to PrE. Interestingly, this work also
highlighted the importance of ROS in the differentiation process as reducing ROS levels
with antioxidants attenuates differentiation [18]. The mechanism by which ROS acts on
PrE differentiation is unknown, but evidence from other systems and tissue culture
models suggests that it may involve Nucleoredoxin (NRX).
Amino acid sequence similarity indicates that NRX is part of the Thioredoxin (TRX)
family of redox proteins [26]. TRX is a ubiquitously expressed, evolutionarily conserved

10
protein containing a redox active site, Cysteine-X-X-Cysteine (CXXC). TRX catalyzes
NADPH dependent reductions of disulfide bridges and functions as a disulfide
oxidoreductase. Under oxidizing conditions, the thiol functional group on the two
cysteine residues form a disulfide bridge capable of changing protein function or proteinprotein interactions [27]. In terms of TRX, this disulfide bridge can be reduced by
thioredoxin reductase and NADPH.
Evidence from whole-mount in situ hybridizations studies using mouse embryos
suggests that NRX plays a role in patterning various tissues/regions during
embryogenesis [26, 28]. Specifically, these in situ patterns show strong NRX expression
in the limb buds and somites [26]. To date reports detailing the effects of knocking out
the NRX gene in mouse embryos indicate embryos are smaller than their littermates and
exhibited craniofacial defects with short frontal regions [29, 30], but nothing is known
regarding a role of NRX in ExE development. Recently, investigators using NIH3T3 cells
have reported on the involvement of NRX in canonical Wnt signaling [31]. In this
investigation, immunoprecipitation followed by mass spectrometry revealed that NRX
was a major binding partner of Dvl-1.
In mammals there are three Dvl isoforms: Dvl-1, Dvl-2, and Dvl-3. All isoforms are
expressed during embryonic development and all show a similar, broad expression
pattern, which would suggest that they act in a functionally redundant manner [32].
Studies in mice show that the individual knockouts of Dvl-1, Dvl-2 or Dvl-3 remain
viable, but display defects including, but not limited to social, vertebral, and cardiac
abnormalities. In double knockout studies, however, the absence of Dvl isoforms leads to
more severe phenotypes including embryonic lethality [33], which would indicate that the
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remaining isoform is not capable of assuming the role(s) left vacant due to the knockout.
Incidentally, F9 cells express all three Dvl isoforms, with Dvl-2 constituting 95% of the
Dvl pool [34]. Therefore, for the purpose of my research, all three Dvl isoforms were
analysed, but emphasis was placed on Dvl-2.
The structure of Dvl is conserved amongst the three isoforms and includes three main
protein binding domains allowing for Dvl to interact with over 60 proteins [35]. The DIX
domain located at the N-terminus is involved in binding to Axin, a negative regulator of
Wnt signaling. A central PDZ domain is involved in binding a large number of proteins
including CK1 and NRX [31]. Lastly, the DEP domain, located at the C-terminus of Dvl,
is thought to function in G-protein signaling [32].

1.6 Role of Nucleoredoxin in development and rationale
for further research
At the onset of my study, the report of an increase in ROS levels following RA
treatment of F9 cells, and the ability of H2O2 to induce differentiation in an RAindependent manner [18] left many unanswered questions. Interestingly, recent studies
demonstrating that redox regulated proteins act on the canonical Wnt pathway [31] point
to a general phenomenon where ROS play a regulatory role in signal transduction events.
Furthermore, the observation that the amount of Dvl-1-bound to NRX increases under
reduced conditions, and decreases when cells are subjected to oxidizing conditions [31],
would suggest that the redox state of the cell is key in the regulation of these events. In
this manner, the binding of NRX to Dvl would be expected to augment the negative
regulation of β-catenin in the Wnt pathway via the destruction complex. In contrast, when

12
cells are exposed to oxidizing conditions, NRX would dissociate from Dvl, allowing it to
await the Wnt signal and transduce it by destabilizing the β-catenin destruction complex
[31] (Fig. 1.3). Thus, in this model, NRX serves as an inhibitor in the canonical Wnt
signaling pathway. This model is supported by evidence from NRX knockout studies,
where NRX-/- causes perinatal lethality due to dysregulation of Wnt/β-catenin signaling
[29, 35]. What these knockout studies do not explain is the fact that defects are noted
later in development and not at earlier stages, where Wnt signaling is known to be
involved in ExE formation.

1.7 Objectives and Hypothesis
The objective of this research was to further address the role of NRX and Wnt
signaling during vertebrate early development with a specific focus on EMTs and ExE
differentiation. Observations from our lab have shown that in F9 cells, RA induction of
PrE differentiation causes an upregulation of Wnt6 and activation of the canonical Wnt/βcatenin pathway. Furthermore, these changes are accompanied by an increase in the
levels of ROS. Based on these results, together with results from the literature indicating
that NRX dissociates from Dvl-1 when NIH3T3 cells are treated with H2O2, I
hypothesize that during RA-induced activation of the canonical Wnt pathway in F9
cells, the accompanied increase in ROS leads to dissociation of NRX from Dvl,
thereby augmenting the accumulation of β-catenin in the nucleus that is necessary
for ExE differentiation. To examine the role of NRX in Wnt signaling and ExE
differentiaton, the mRNA and protein expression profiles of NRX, Dvl-1, Dvl-2 and Dvl-3
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in undifferentiated and RA treated F9 cells were determined. Next, coimmunoprecipitation assay was used to investigate the relationship between NRX and
Dvl-2 under reducing and oxidizing condition. Finally, sh-NRX was used to knock down
NRX to assess the effects on ExE formation.
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Figure 1.3 Increase in ROS causes NRX dissociation from Dvl and enhances canonical
Wnt signaling. Recent evidence suggests that in the absence of Wnt, NRX binds to Dvl
and augments the negative regulation of β-catenin via the destruction complex. Following
an increase in ROS, the thiol functional group on the two cysteine residues of NRX form
a disulfide bridge, changing the conformation of NRX, thereby allowing it to dissociate
from Dvl. This release of Dvl inactivates the destruction complex, thus allowing βcatenin to accumulate and subsequently translocate to the nucleus where it binds to TCFLEF to induce Wnt target genes.
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Chapter 2
2 Materials and Methods

2.1 Cell Culture
F9 cells (ATCC) were cultured in Dulbecco’s modified Eagle’s medium (Gibco)
supplemented with 1 % penicillin-streptomycin (Gibco) and 10 % fetal bovine serum
(Gibco) and incubated at 37oC and 5 % CO2. Cells were treated with dimethyl sulphoxide
(DMSO), serving as a control, 10-7 M retinoic acid (RA all-trans; Sigma), or 0.05 mM
and 0.1 mM H2O2 (EMD). Further analysis of cell differentiation was tested using RA
plus 0.05 mM dibutyryl cyclic adenosine monophosphate (db-cAMP; Sigma), or H2O2
and db-cAMP.
For antioxidant analysis, F9 cells were first treated with 1 mM and 2 mM NAcetyl-L-cysteine (NAC; Sigma), or 0.1 mM and 0.5 mM L-Ascorbic acid (Vitamin C;
Sigma) for 24 h, and then treated with 10-7 M RA. NAC, Vitamin C and RA were
replenished every day for 3 days.

2.2 Reverse Transcription PCR and Quantitative Reverse
Transcription PCR
Total RNA was collected using the RNeasy kit (Qiagen) and converted into first
strand cDNA using reverse transcriptase qScript cDNA Supermix (Quanta). RNA was
isolated following treatment of F9 cells with DMSO, RA (for 1, 2, 3 and 4 days), H2O2
(for 1, 2, and 3 days) or RA/H2O2 and db-cAMP. Primers were designed to: L14 sense
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(5’GGGAGAGGTGGCCTCGGACGC)

and

antisense

(5’GGCTGGCTTCACTCAAAGGCC) to produce a 300 bp product. L14 is a
constitutively expressed gene in F9 cells and used as an internal control. NRX sense (5’
TCTGCTCACCATTCTGGACA) and antisense (5’ACACGCTGGAAAAGTCCAAG)
to produce a 200 bp product, Gata6 sense (5’CTCTGCACGCTTTCCCTACT) and
antisense (5’GTAGGTCGGGTGATGGTGAT) to produce a 200 bp product, FoxA2
sense

(5’ACCTGAGTCCGAGTCTGAGC)

and

antisense

(5’CATGGTGATGAGCGAGATGT) to produce a 200 bp product, TM sense
(5’CCAGGCTCTTACTCCTGTA) and antisense (5’TGGCACTGAAACTCGCAGTT)
to produce a 200 bp product. Primers were also designed for Dvl-1 sense
(5’CATCCTCCTTCAGCAGCATCAC)

and

antisense

(5’ACTCGTACCATAGCGGGGC) to produce a 450 bp product, Dvl-2 sense
(5’AGACTCGGATGAGGATGACA) and antisense (5’AAGGCTCCAGTCAGCGCA)
to produce a 550 bp product, and Dvl-3 sense (5’TGGGGCTGTGGCAGCTGATGG) and
antisense (5’GAGGCCATGGCTTTTACGATG) to produce a 400 bp product [36].
Primers were used with first strand cDNA template for reverse transcriptasepolymerase chain reaction (RT-PCR) using a thermocycler (Eppendorf) and the following
conditions: NRX – 35 cycles of 30 s at 94oC, 30 s at 55oC, and 30 s at 72oC; Dvl-1 – 40
cycles of 30 s at 94oC, 30 s at 55oC, and 30 s at 72oC; Dvl-2 – 38 cycles of 30 s at 94oC,
30 s at 55oC, and 30 s at 72oC; Dvl-3 – 42 cycles of 30 s at 94oC, 30 s at 60oC, and 30 s at
72oC; Gata6 – 35 cycles of 30 s at 94oC, 30 s at 57oC, and 30 s at 72oC; FoxA2 – 35
cycles of 30 s at 94°C, 30 s at 58°C, and 30 s at 72°C; TM – 32 cycles of 30 s at 94oC, 30
s at 57oC, and 30 s at 72oC . PCR products were analyzed on 1 % agarose gels containing
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ethidium bromide and DNA was visualized using a FluorChem 8900 Gel Doc System
(Alpha Innotech). All amplicons were sequenced at the Roberts’ Research Institute
(UWO), to confirm their identity.
Quantitative reverse transcription-PCR (qRT-PCR) analysis was carried out in
triplicate using the Rotor Gene 3000 (Corbett). Each reaction contained 1 μL of cDNA,
500 nM concentrations of each of the primers described above, and a PerfeCTa SYBR
green PCR Fastmix (Quanta Biosciences). Gene expression analysis was performed using
the comparative cycle threshold (Ct) method, normalized to L14 expression, and the fold
changes were calculated relative to control DMSO-treated cells.

2.3 Immunoblot Analysis
Protein lysates were collected in 2 % sodium dodecyl sulfate (SDS) buffer
containing 0.5 M Tris-HCl pH 6.8 (BioShop), 5 % glycerol, 5 % 2-mercaptoethanol
(BDH), 2 % SDS (BioShop) and 1 % Halt Protease Inhibitor Cocktail (Thermo
Scientific). Protein concentrations were determined using a Bradford Assay (Bio-Rad).
Approximately 40 μg of protein were separated on denaturing 10 % polyacrylamide gels
for 1.5 h at 120 volts. Following electrophoresis, the proteins were electrophoretically
transferred for 1 h to nitrocellulose membranes (Biotrace; Pall Corp.) using Tris-glycine
transfer buffer containing 20 % methanol. The membranes were blocked in Tris buffered
saline containing 0.1 % Tween 20 (TBS-T) and 5 % skim milk for 1 h at room
temperature. Membranes were then probed with primary antibody(s) overnight at 4oC
followed by 3 washes in TBS-T, and then probed with secondary antibody(s) for 2 h at
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room temperature. Signals were detected using the SuperSignal West Pico
Chemiluminescent Detection Kit (Pierce) and X-Omat Blue XB-1 Film (Kodak) or
captured on a Molecular Imager Gel Doc XR System (BioRAD) and imaged using
Quantity One Software. The primary antibodies were directed against TROMA-1 (1:10;
55 kDa, Developmental Studies Hybridoma Bank), β-Actin (1:10000; 47 kDa, Santa
Cruz), NRX (1:250; 55 kDa, Santa Cruz), Dvl-1 (1:250; 85 kDa, Santa Cruz), Dvl-2
(1:250; 92 kDa, Santa Cruz) and Dvl-3 (1:200; 81 kDa, Santa Cruz) and dissolved in 5 %
Bovine Serum Albumin (BSA; OmniPur) and TBS-T. Secondary antibodies including
HRP-conjugated anti-goat, anti-rat and anti-mouse (1:5000; Pierce) were dissolved in 5
% skim milk and TBS-T.

2.4 Co-Immunoprecipitation
Cells grown to approximately 80 % confluency were treated with 1 mM
dithithreitol (DTT; New England BioLabs) or 1 mM H2O2 for 15 min and protein lysates
were collected in nonyl phenoxypolyethoxylethanol-40 lysis buffer (NP-40) containing
50 mM Tris pH 7.2 (BioShop), 100 mM NaCl (BioShop), 0.1 % IGEPAL (Sigma), 10 %
glycerol, 1 mM ethylenediaminetetraacetic acid (EDTA; Gibco) and 0.1 mM
phenylmethylsulfonyl fluoride (PMSF; Sigma). Lysates were incubated in NP-40 lysis
buffer for 10 minutes then passed through a 25-gauge needle 15 times and centrifuged for
10 min at 4ºC. To immunoprecipitate proteins bound to Dvl-2, protein lysate (2 mg/mL)
was first pre-cleared using a 20 μL sepharose bead volume (Protein A/G PLUS Agarose
Immunoprecipitation Reagent; Santa Cruz) for 1 h. Lysates were then treated overnight at
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4ºC with either 1 μg of anti-Dvl-2 antibody or 1 μg of IgG normal mouse serum (Santa
Cruz), as a control. Antibody-protein complexes were then immobilized on sepharose
beads for 2 h at 4ºC. Bound proteins were washed three times with NP-40 lysis buffer,
eluted from the beads using electrophoresis sample buffer (New England BioLabs),
resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE),
and then blotted to nitrocellulose membrane. The membrane was blocked with TBS-T
and 5 % skim milk for 1 h, and then probed with anti-NRX antibody (1:250) overnight at
4ºC and then with an HRP-conjugated anti-goat antibody (1:5000) for 2 h. To confirm the
pull-down of Dvl-2, membranes were stripped and reprobed with anti-Dvl-2 antibody
(1:250) and HRP-conjugated anti-mouse antibody (1:5000).

2.5 sh-NRX construct and Knockdown
The following sequence derived from the mouse NRX cDNA was used for the
knockdown of NRX: (AA)GATCATTGCCAAGTACAAA [31]. Oligonucleotide primers
designed to amplify the above sequence was used with PCR to clone the NRX sh-RNA
into the pRS shRNA vector (a generous gift from Dr. Robert Cumming; sh-NRX). Cells
were transfected with sh-NRX, or with pRS or CMV-GFP constructs as negative and
transfection efficiency controls, respectively, using Lipofectamine 2000 and according to
the manufacturer's protocol (Invitrogen). Briefly, F9 cells grown to approximately 90 %
confluency were transfected with 10 uL of Lipofectamine 2000 and 4 ug of each of the
constructs in 2 mL of Opti-MEM (Invitrogen). Opti-MEM was replaced with complete
media 5 h post transfection and cells were cultured for 3 days. For differentiation to PE
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analysis, Opti-MEM was replaced with complete media plus db-cAMP (0.05 mM).
mRNA was collected using methods described previously (section 2.2), while protein
lysates were collected in 2 % SDS lysis buffer.

2.6 Microscopy
Cells were examined under bright field using a Zeiss Axio Observer A1 inverted
microscope and images were captured using a QImaging Retiga CCD camera. All images
were assembled as plates using Adobe Photoshop CS3 and Adobe Illustrator CS3.

2.7 Statistical Analysis
Densitometric analyses of immunoblots and quantitative reverse transcription PCR
data were compiled from three independent biological replicate experiments performed
on separate occasions. Comparisons of data between the control and treated, or
transfected groups were performed using a one-way ANOVA and Tukey's HSD post-hoc
tests (SPSS). Data is presented as mean and standard error of the mean. The p values
were one-sided and considered statistically significant at the 0.05 level.
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Chapter 3
3 Results
3.1 RA, H2O2 and db-cAMP induce differentiation of F9
cells
Previous work in our lab has demonstrated an accompanied increase in ROS levels
when F9 cells are treated with RA to induce PrE differentiation. Moreover, cells also
differentiate to PrE when they are treated with H2O2 [18]. To confirm these results, cells
were treated with RA or H2O2, and then examined for markers of differentiation. RA
treatments were examined over a 4 day period and compared to DMSO-vehicle treated
cells. Morphological analysis showed DMSO treatments caused cells to appear compact,
while treatment with RA showed cells acquiring a more flattened morphology as they
moved apart from one another. Similarities in morphology to RA-treated cells occurred
when cells were treated with 0.1 mM H2O2 for 3 consecutive days (Fig. 3.1A).
Previous work has shown that the addition of db-cAMP to RA-treated F9 cells
cause them to further differentiate to PE [7]. Although this ability to chemically induce
F9 cells to form PE is well known, no report had documented whether H2O2 in the
presence of db-cAMP would have the same outcome. To this end, F9 cells were treated
with either RA or H2O2, and subsequently with db-cAMP. Results show that the addition
of H2O2 and db-cAMP caused F9 cells to adopt a similar morphology as RA and dbcAMP. In each case cells that have moved away from the compact mass displayed
extended protrusions and appeared more refractile than those exposed to RA or H2O2
alone (Fig. 3.1A).
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Figure 3.1 RA and H2O2 induce morphological changes and markers of primitive
endoderm; with the addition of db-cAMP cells become competent to form parietal
endoderm. F9 cells were treated with DMSO, RA (10-7 M), H2O2 (0.1 mM), RA and dbcAMP (0.05 mM) or H2O2 and db-cAMP. (A) F9 cells treated with DMSO grow in
tightly compact groups (top), whereas those treated with H2O2 show a flattened, more
elongated morphology, similar to that of RA-treated cells (middle). H2O2-treated cells
exposed to db-cAMP become refractile, and show extended protrusions reminiscent of
RA and db-cAMP (bottom). (B) Immunoblot analysis for TROMA-1 shows expression
induced by RA treatments, with the highest levels present on day 4. (C) Immunoblot
analysis shows expression of TROMA-1 increased by H2O2 treatment, with the highest
levels present on day 3. (D) RT-PCR analysis shows increased TM in cells treated with
RA and db-cAMP and in those treated with H2O2 and db-cAMP. Data represents 3
independent experiments. Scale bars = 20 μm.
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Immunoblot analysis, using the TROMA-1 antibody to detect the characteristic
assembly of cytokeratin A intermediate filaments that is seen in PrE, was used to confirm
the morphological changes that resulted from RA and H2O2 treatments. As expected,
TROMA-1 signals were not seen in DMSO treated control cells, but were present after
RA treatment, with the highest level after 4 days (Fig 3.1B). Likewise, a similar pattern
of TROMA-1 staining was seen in H2O2 treated cells. DMSO had no effect on TROMA-1
levels, while treatment with H2O2 for 3 days caused an increase (Fig. 3.1C). These
morphological and molecular results confirmed that F9 cells treated with either RA or
H2O2 had differentiated into PrE [18].
Since H2O2 was able to take the place of RA and direct cells into the PrE lineage,
the next question was to test whether these H2O2-induced cells were competent to further
differentiate into PE. RT-PCR was used to detect Thrombomodulin (TM), a marker of PE
differentiation. As expected, TM was not detected in DMSO, RA, or H2O2 treatments, but
with the addition of db-cAMP the expression of TM increased (Fig. 3.1D). Together,
these results indicated that H2O2/db-cAMP treatment was sufficient to induce F9 cells to
form PE.

3.2 Antioxidants attenuate RA-induced differentiation
Studies from the Kelly lab have shown that increasing ROS levels in F9 cells is
sufficient to induce them to differentiate into PrE, while blocking ROS production
through addition of antioxidants inhibits differentiation [18]. To confirm these studies, F9
cells were treated with DMSO, RA or increasing concentrations (1 mM and 2 mM) of N-
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Acetyl Cysteine (NAC) supplemented with RA. To determine if the block to
differentiation was NAC-specific, F9 cells were also treated with various concentrations
(0.1 mM and 0.5 mM) of the antioxidant ascorbic acid, the reduced form of Vitamin C,
and then exposed to RA.
Immunoblot analysis showed no TROMA-1 signal when cells were treated with
DMSO alone, but signals were seen in RA-treated cells (Fig. 3.2A). Compared to RA
alone, cells treated with NAC or Vitamin C showed weaker TROMA-1 signals (Fig.
3.2A). Densitometry analysis comparing TROMA-1 levels relative to the β-actin loading
control was performed. Results indicate that in comparison to RA, TROMA-1 levels
decreased significantly in cells treated with 1 mM and 2 mM NAC and in those treated
with 0.5 mM Vitamin C (Fig. 3.2B). While a concentration of 0.1 mM Vitamin C showed
a decrease in TROMA-1, these levels were not found to be significant. As expected, cells
treated with DMSO had TROMA-1 levels that were significantly lower than the RA,
positive control. Together, these results indicate that exposure to antioxidants inhibits
RA-induced differentiation of F9 cells into PrE, suggesting that ROS are necessary and
sufficient for this to process to occur.

3.3 Dvl-1, Dvl-2 and Dvl-3 mRNA expression profiles
remain constant after RA treatment
In the presence of Wnt, Dvl is recruited to the plasma membrane and acts to
disassemble a destruction complex that otherwise would target β-catenin for proteasomal
degradation. Since RA is known to affect the expression of many genes [11], including in
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Figure 3.2 Antioxidants NAC and Vitamin C attenuate RA-induced differentiation in F9
cells. F9 cells were treated with NAC (1 mM and 2 mM) or Vitamin C (0.1 mM and 0.5
mM) for one day, and then treated with RA (10-7 M). Cells treated with DMSO or RA
(10-7 M) served as a control. (A) Immunoblot analysis for TROMA-1 showing levels of
endo-A cytokeratin in cells treated with RA, but not in the DMSO control. These levels
decreased when cells were treated with NAC and then exposed to RA, or when treated
with Vitamin C and then RA. (B) Densitometry analysis show that there was a significant
decrease in the TROMA-1-positive signals in cells treated with NAC (1 mM and 2 mM)
or Vitamin C (0.5 mM) and RA, compared to those treated with RA alone. TROMA-1
was not significantly different in cells treated with Vitamin C (0.1 mM) plus RA,
compared to those treated with RA alone. Densitometry was calculated by comparing the
TROMA-1/β-actin ratio of each treatment to the same ratio in the RA control treatment.
Asterisks denote significant difference (p≤0.05). Data represents the mean and standard
error of three independent experiments.
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Wnt6 [16], the possibility exists that other members of the canonical Wnt signaling
pathway, and in particular Dvl, may be regulated at either the mRNA or protein level in
F9 cells treated with RA. To address this, the relative mRNA levels of all three Dvl
isoforms were analysed to determine if the Dvl genes are RA-responsive.
The mRNA expression profile of Dvl-1, Dvl-2 and Dvl-3 was determined in cells
treated with DMSO or RA for 1 to 4 days. RT-PCR was employed and amplicons
confirmed that all three Dvl isoforms are present in F9 cells; however, relative levels
appeared similar between the RA-treated and DMSO control cells (Fig. 3.3A-C). Since
these levels appeared constant, it was necessary to use qRT-PCR to determine if subtle
differences in expression exist. The expression levels of Dvl-1, 2 and 3, normalized to
L14, was determined in RA-treated cells and compared to the vehicle control. Results
confirmed there was no significant change in the expression levels of Dvl-1, 2 or 3 in RAtreated cells compared to DMSO (Fig. 3.3D-F). To confirm these results, these mRNA
expression levels were compared to that of a known RA-responsive gene, Gata6 [12].
qRT-PCR results showed that Gata6 expression increased at 1 day post-RA treatment and
continued to increase significantly through day 4 (Fig. 3.3G). In light of the Gata6
expression, it would appear that Dvl-1, Dvl-2 and Dvl-3 are not RA-responsive genes.

3.4 Dvl-1, Dvl-2 and Dvl-3 protein expression profiles
remain constant after RA treatment
Since there were no obvious changes in the levels of Dvl-1, 2 or 3 mRNA in response
to RA, I decided to use immunoblot analysis to investigate Dvl-1, 2 and 3 protein levels
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Figure 3.3 Dvl-1, Dvl-2 and Dvl-3 mRNA levels are not affected by RA treatment. F9
cells were treated with DMSO or RA (10-7 M) for 1 to 4 days and total RNA was
collected, reverse transcribed into first strand cDNA, and used as template for PCR
analysis with primers designed to Dvl-1, Dvl-2 and Dvl-3. (A-C) Three separate RT-PCR
experiments show all three Dvl genes are expressed in both DMSO and RA-treated cells.
(D-F) qRT-PCR analysis shows that there was no significant difference in the transcript
level of any Dvl. (G) qRT-PCR, with primers designed to Gata6, an RA-responsive gene,
show that there is a significant increase in Gata6 expression in cells following treatment
with RA. For qRT-PCR analysis, the expression levels of Dvl-1, -2, -3 and Gata6 were
normalized to L14 and compared to the vehicle control. Asterisks denote significant
difference (p≤0.05). Data represents the mean and standard error of three independent
experiments.
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under the same conditions. Antibodies against each specific Dvl were used on blots
containing proteins isolated from DMSO or RA-treated cells. A β-actin antibody was
used to ensure equal loading between samples. Results show that Dvl-1, 2 and 3 were
present in both vehicle-treated and RA-treated cells (Fig. 3.4A-C). Furthermore,
densitometry analysis confirmed that there were no significant changes in the levels of
each Dvl isoform in either DMSO or RA-treated cells (Fig. 3.4D-F).

3.5 NRX mRNA expression profile remains constant after
RA treatment
Since Dvl was not RA-responsive as RA had no effect on the steady state levels of
any of the three Dvl isoforms, the focus turned to NRX, a protein known to interact with
Dvl [31] and one that is redox sensitive [26]. These results were particularly intriguing
given the effects of treating F9 cells with H2O2 (described above in section 3.1). First, to
determine if the expression of NRX changed in response to RA, cells were treated with
RA for 1 to 4 days and total RNA was collected. The RNA was then reverse transcribed
into first strand cDNA and used as a template for PCR with NRX specific primers.
Results show that NRX was present in DMSO-treated (undifferentiated) F9 cells (Fig.
3.5A). Furthermore, the levels of NRX appeared to remain constant following RA
treatment. qRT-PCR was used to determine if there were any subtle changes in NRX
expression. Results, normalized to the vehicle control and compared to RA treatments at
days 1 to 4, show that there were no significant changes in NRX expression between
DMSO and RA-treated cells (Fig. 3.5B).
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Figure 3.4 Dvl-1, Dvl-2 and Dvl-3 protein levels are not affected by RA treatment. F9
cells were treated with DMSO or RA (10-7 M) for 1 to 4 days and protein lysates were
collected and used for immunoblot analysis with antibodies against Dvl-1, Dvl-2 and
Dvl-3. (A-C) Immunoblot showing Dvl-1, Dvl-2, and Dvl-3 in DMSO and RA-treated F9
cells. Note that the relative levels of Dvl-1, Dvl-2 and Dvl-3 did not change following
treatment. (D-F) Densitometry analysis confirms that there were no significant changes in
Dvl-1, Dvl-2 or Dvl-3 protein levels following either DMSO or RA treatment.
Densitometry was calculated by comparing the Dvl-1, -2, -3/β-actin ratio of each
treatment to the same ratio in the vehicle control treatment. Asterisks denote significant
difference (p≤0.05). Data represents the mean and standard error of three independent
experiments.
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Figure 3.5 NRX mRNA levels are not affected by RA treatment. F9 cells were treated with
DMSO or RA (10-7 M) for 1 to 4 days. Total RNA was collected, reverse transcribed into
first strand cDNA, and used as template for PCR analysis with primers designed to NRX.
(A) RT-PCR results show that the NRX mRNA transcript is present after treatment with
DMSO or RA. (B) qRT-PCR data confirmed that there were no significant differences in
mRNA transcript levels of NRX between treatments. For qRT-PCR analysis, the
expression level of NRX was normalized to L14 and compared to the vehicle control.
Asterisks denote significant difference (p≤0.05). Data represents the mean and standard
error of three independent experiments.
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Unlike Gata6 (Fig. 3.3G), these results strongly suggest that NRX is not RAresponsive.

3.6 NRX protein expression profile remains constant after
RA treatment
To complete my analysis of NRX it was necessary to determine if RA affected the
steady state levels of the protein. Total protein lysates from cells treated with DMSO or
RA for 1 to 4 days were separated, transferred to membranes and then probed with either
an NRX antibody or an antibody for β-actin, the latter protein serving as a loading
control. Results show NRX bands, of the expected molecular mass, in DMSO and RAtreated cells (Fig. 3.6A). Furthermore, densitometry analysis showed no significant
change in NRX protein levels between treatments (Fig. 3.6B). These results, like those
for Dvl, show that NRX is expressed in undifferentiated F9 cells as well as in PrE cells
induced by RA. Thus, if NRX can regulate Dvl and keep F9 cells in an undifferentiated
state when Wnt ligands are absent, then the apparent inability of RA to alter the steadystate levels of either of these proteins would suggest that some other post-translational
mechanism of regulation must be in effect.

3.7 Interaction between NRX and Dvl-2 is redox regulated
Given that F9 cells treated with RA demonstrate increased Wnt6 expression and
differentiate into PrE and that this increase is accompanied by a concomitant increase in
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Figure 3.6 NRX protein levels are not RA responsive. F9 cells were treated with DMSO
or RA (10-7 M) for 1 to 4 days and protein lysates were collected and used for
immunoblot analysis. (A) Immunoblot showing relative NRX levels after cells were
treated with DMSO or RA. NRX protein levels were not affected by RA treatment. (B)
Densitometry results show no significant change in NRX protein levels in DMSO or RA
treated cells. Densitometry was calculated by comparing the NRX/β-actin ratio of each
treatment to the same ratio in the vehicle control treatment. Asterisks denote significant
difference (p≤0.05). Data is representative as the mean and standard error of three
independent experiments.
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the levels of ROS, and treating F9 cells with H2O2 also induces differentiation [18], it is
tempting to speculate that the redox state of the cell impacts on canonical Wnt signaling
required for differentiation. The studies with NIH3T3 cells, showing that the interaction
between NRX and Dvl-1 is redox regulated, also lends support to this model, implicating
ROS signaling crosstalk with the Wnt pathway. Since NRX and Dvl are not responsive to
RA in F9 cells, the possibility therefore exists that the increase in ROS following RA
treatment plays a post-translational role in regulating the interaction between NRX and
Dvl. If this is the case, then the ROS might be expected to cause disulfide bridge
formation in the CXXC site of NRX, altering its conformation and affecting its ability to
interact with Dvl. If my hypothesis is correct, then I expect to find NRX bound to Dvl in
untreated F9 cells. Likewise, I predict that NRX would dissociate from Dvl when F9 cells
are exposed to increasing levels of ROS. As noted above, Dvl-2 is the most abundant of
the Dvl isoforms in F9 cells. I thus chose to further examine the relationship between
NRX and Dvl-2.
To test my hypothesis, F9 cells were cultured and treated with H2O2, DTT (a strong
reducing agent) or left untreated. Whole cell lysates were isolated and
immunoprecipitated using an anti-Dvl-2 antibody to test the interaction between Dvl-2
and NRX. Normal mouse IgG was used as a negative control to assess for non-specific
binding (Fig. 3.7A Lane 1). Following immunoprecipitation, immunoblot analysis
revealed that in untreated cells, NRX binds to Dvl-2 (Lane 2). This interaction between
NRX and Dvl-2 increased under strong reducing conditions (Lane 3), while under
oxidizing conditions it appeared that the level of NRX bound to Dvl-2 decreased (Lane
4). Densitometry analysis was then used to assess the relative amounts of NRX-bound to
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Figure 3.7 The interaction between NRX and Dvl-2 in F9 cells is redox-dependent. Cells
were either untreated, or treated with DTT (1 mM) or H2O2 (1 mM) for 15 min and
protein lysates were collected. Protein complexes were immunoprecipitated with an antiDvl-2 antibody or with an IgG Normal Mouse as a control. (A) Immunoblot results show
that compared to controls, NRX levels pulled down with Dvl-2 decrease when cells were
treated with H2O2. In converse, cells treated with DTT show that more NRX was pulled
down in the Dvl-2 complex. (B) Densitometry analysis confirmed that NRX protein
levels were significantly less in H2O2-treated cells compared to those treated with DTT.
Densitometry was calculated by comparing the NRX/Dvl-2 ratio of DTT and H2O2
treatments to the same ratio in the untreated control. Asterisks denote significant
difference (p≤0.05). Data is representative as the mean and standard error of three
independent experiments.
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Dvl-2 under the different treatment regimes (Fig. 3.7B). The data represent NRX bound
to immunoprecipitated Dvl-2, and normalized to the levels of Dvl-2 pulled down. There
was a significant difference in the amount of NRX bound to Dvl-2 when cells were
subjected to DTT compared to H2O2 treatment (p=0.03). While there were differences in
the amount of NRX bound to Dvl-2 in DTT and H2O2, compared to that in untreated cells,
these differences were not significant (p=0.06 and p=0.80 respectively). These results
provide evidence that NRX interacts with Dvl-2 in F9 cells, and furthermore that this
relationship is redox dependent.

3.8 NRX knockdown differentiates F9 cells to PrE
NRX inhibits Dvl in the absence of Wnt, causing degradation of β-catenin and
thus preventing the interaction between β-catenin and TCF-LEF [31]. In F9 cells, NRX is
bound to Dvl-2 and the increase in ROS, following RA-induced Wnt activation, may
affect the redox interaction between NRX and Dvl-2. That said, if ROS induce a
conformational change in NRX this would free up a pool of Dvl, thereby priming it to be
recruited to the plasma membrane if and when a Wnt ligand presents itself to a Fzd
receptor. On the other hand, freeing up Dvl may be sufficient to activate the pathway in
the absence of Wnt, as evident from studies showing the overexpression of Dvl alone
upsets the stoichiometry of the Wnt pathway leading to activation [37]. In any event, the
end result would be the accumulation of β-catenin, its translocation into the nucleus and
its subsequent interaction with TCF-LEF to impart changes in gene expression necessary
for PrE differentiation. If this premise is true, then knocking down NRX should release
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the inhibition of Dvl and, in the absence of RA, free up enough Dvl to activate β-catenindependent gene expression needed for cells to differentiate into PrE.
To address my hypothesis, NRX was knocked down by transfecting F9 cells with a
shRNA that specifically targets NRX. Changes in morphology were then evaluated using
phase contrast microscopy. F9 cells were also transfected with the pRS empty vector
plasmid (pRS-EV) as a control. Morphologically, cells transfected with pRS-EV and
those treated with DMSO are similar and show cells growing in compact bodies,
reminiscent of undifferentiated cells (Fig. 3.8A). Cells transfected with sh-NRX were
elongated and flattened and showed changes in morphology including protrusions that
differed from DMSO or pRS-EV-transfected cells. Interestingly, the sh-NRX morphology
appeared similar to that caused by RA, suggesting the NRX knockdown was able to
differentiate cells into PrE (Fig. 3.8A).
To test whether or not the NRX knockdown had induced cells to differentiate into
PrE, protein lysates were collected for cells treated with DMSO or RA or transfected with
pRS-EV or sh-NRX. Immunoblot analysis and the TROMA-1 antibody were used to
detect the expression of cytokeratin intermediate filaments, a marker of PrE. An antiNRX antibody was used to confirm the knockdown and β-actin was used to ensure equal
amounts of protein were assayed between the different regimens. As expected, TROMA1 levels appeared higher in RA treated cells compared to those treated with DMSO (Fig.
3.8B). TROMA-1 levels also appeared higher in cells transfected with sh-NRX compared
to those transfected with pRS-EV (Fig. 3.8B). Densitometry data confirmed these results,
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Figure 3.8 NRX knockdown increased endo-A cytokeratin levels indicative of
extraembryonic endoderm differentiation. F9 cells transfected with sh-NRX or pRS-EV or
treated with DMSO or RA (10-7 M), as controls, were examined morphologically or
processed for immunoblot analysis using the TROMA-1 antibody to detect endo-A
intermediate filaments. (A) F9 cells transfected with pRS-EV are morphologically similar
to cells treated with DMSO, appearing in tightly compact groups reminiscent of
undifferentiated cells. In contrast, F9 cells transfected with sh-NRX show a flattened,
more elongated morphology, comparable to RA-treated differentiated primitive endoderm
cells. (B) Immunoblot analysis with the TROMA-1 antibody indicates that endo-A
intermediate filaments were present in cells transfected with sh-NRX, but not in cells
transfected with the empty vector. This increase was seen in the RA-treated positive
controls, but not in the DMSO negative control. Antibodies to NRX confirmed the
efficiency of the NRX knockdown, while antibodies to β-actin was to ensure equal
loading between samples. (C) Densitometry analysis confirmed that there was a
significant increase in TROMA-1 positive signal when cells were transfected with shNRX or treated with RA compared to those transfected with pRS-EV or treated with
DMSO, respectively. Densitometry was calculated by comparing the TROMA-1/β-actin
ratio of RA and sh-NRX to the same ratio in the vehicle and pRS-EV control respectively.
Asterisks denote significant difference (p≤0.05). Data is representative as the mean and
standard error of three independent experiments. Scale bars = 20 μm.
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and showed there was a significant increase in TROMA-1 levels in RA-treated cells
compared to those seen in DMSO treatments (Fig 3.8C). These levels were comparable to
the significant increase seen in TROMA-1 levels resulting from the NRX knockdown
(Fig. 3.8C). Thus, in the absence of RA, NRX knockdown in F9 cells is sufficient to
induce PrE.

3.9 NRX knockdown plus db-cAMP differentiates F9 cells
to PE
Since knocking down NRX caused cells to differentiate into PrE, the question
remained as to whether or not F9 cells deficient in NRX were competent, under the right
conditions, to differentiate into PE. To test this notion, sh-NRX transfected cells were
treated with db-cAMP. As a control, cells were transfected with pRS-EV and treated with
db-cAMP. Morphologically, cells transfected with pRS-EV and treated with db-cAMP
were indistinguishable from those treated with DMSO. Both treatments showed cells
growing in compact bodies, reminiscent of undifferentiated cells (Fig 3.9A). In contrast,
cells transfected with sh-NRX and treated with db-cAMP were morphologically similar to
those treated with RA and db-cAMP. sh-NRX-transfected and db-cAMP-treated cells
exhibited the hallmark features of PE cells that had been induced by RA and db-cAMP,
including extended cell protrusions and a refractile appearance (Fig. 3.9A).
Next, mRNA was isolated and converted into cDNA for a qRT-PCR analysis to
confirm that the morphological changes resulting from the NRX knockdown were
associated with decreased levels of NRX expression. qRT-PCR results show cells
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Figure 3.9 F9 cells transfected with sh-NRX and treated with db-cAMP form parietal
endoderm. Total RNA from F9 cells transfected with pRS-EV or sh-NRX, or transfected
with pRS-EV or sh-NRX and then treated with db-cAMP was isolated, reverse transcribed
into first strand cDNA, and used as template for PCR analysis with primers designed to
NRX, TM, and L14 (control). RNA was also collected from cells treated with DMSO, RA
(10-7 M), or RA and db-cAMP (0.05 mM). (A) F9 cells transfected with pRS-EV and
treated with db-cAMP grow in tightly compact groups, similar to DMSO-treated cells. F9
cells transfected with sh-NRX and then treated with db-cAMP are morphologically
different from controls, having increased cell protrusions and a refractile appearance.
This morphology is reminiscent of cells treated with RA and db-cAMP. (B) qRT-PCR
analysis for NRX confirms that there was a significant decrease in the level of NRX in
cells transfected with sh-NRX and in cells transfected with sh-NRX and treated with dbcAMP. (C) qRT-PCR results show NRX levels at the exponential (cycle 25) and the
plateau (cycle 40) phases. Note that during the exponential phase a NRX amplicon is not
seen in cells transfected with sh-NRX or in those transfected with sh-NRX and then
treated with db-cAMP. An amplicon, however, was seen at the plateau phase. (D) qRTPCR indicates that compared to the empty vector control, there was a significant increase
in TM in cells transfected with sh-NRX and treated with db-cAMP. The same is true for
RA and db-cAMP-treated cells compared to the DMSO control. (E) The TM signal at the
exponential (cycle 29) phase from cells transfected with sh-NRX and then treated with dbcAMP is similar to the signal seen from cells treated with RA and db-cAMP. The
increase in TM expression is seen at the plateau phase under all treatment regimes. For
qRT-PCR analysis, the expression level of NRX and TM was normalized to L14 and
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compared to the vehicle or pRS-EV control. Asterisks denote significant difference
(p≤0.05). Data is representative as the mean and standard error of three independent
experiments. Scale bars = 20 μm.
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transfected with sh-NRX had a significant decrease in NRX levels compared to cells
transfected with the pRS-EV (Fig. 3.9B). To account for the fact that the knockdown was
not 100% efficient, qRT-PCR samples were run in duplicate, stopping one set at the cycle
threshold, the number of cycles at which the dsDNA fluoresces. The second set was run
until completion, the full 40 cycles. Samples from both groups were electrophoresed on
agarose gels and images collected. These results show that after 25 cycles, the cycle
threshold, NRX amplicons were not evident in cells transfected with sh-NRX or in those
transfected sh-NRX and treated with db-cAMP; however, transcript levels of NRX after 40
cycles, the endpoint, show similar NRX transcript levels in all treatments (Fig. 3.9C).
Therefore, visualising NRX at its cycle threshold, using electrophoresis and qRT-PCR
data, indicates the efficiency of the knockdown.
The efficiency of the NRX knockdown was confirmed, and the morphological
changes seen due to the knockdown suggested cells had differentiated to PE. To confirm
the latter, qRT-PCR was used with primers designed against the PE marker TM. Relative
to their respective controls, there was a significant increase in the TM expression in cells
treated with RA and db-cAMP and in cells transfected with sh-NRX and then
subsequently treated with db-cAMP (Fig. 3.9D). Samples were assayed at the cycle
threshold (cycle 29), and at the 40 cycle endpoint (Fig. 3.9E). After 29 cycles, treatments
with DMSO or RA alone had no effect on TM expression. In contrast, TM amplicons
were seen in the RA and db-cAMP positive control. TM amplicons were not detected in
cells transfected with pRS-EV alone, or pRS-EV and then treated with db-cAMP. Finally,
transfecting cells with sh-NRX had no affect on up-regulating the TM gene, but adding
db-cAMP following transfection resulted in increased TM expression. That transcript
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levels of TM after 40 cycles appear similar in all treatments highlights the importance of
validating qRT-PCR data at the cycle threshold of the gene of interest.
Together, these results confirm that the knockdown of NRX alone is not sufficient
to induce F9 cells to differentiate as PE. Likewise, transfecting cells with the pRS-EV
construct and them treating with db-cAMP does not induce cells to PE. Rather, in a
manner that mimics the induction of PE by RA and db-cAMP, the NRX knockdown is
sufficient to induce cells to differentiate as PrE that is competent to differentiate into PE
when challenged with db-cAMP.
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Chapter 4
4 Discussion
Wnt signaling plays numerous roles in vertebrate and invertebrate development and
if the molecular changes seen in the in vitro F9 model are bona fide and directly
recapitulate those in vivo, then we can infer that the redox regulation of the Wnt signaling
pathway is responsible for specifying a select group of ICM cells to differentiate as PrE.
In addition to canonical Wnt/β-catenin signaling, two other pathways involving Wnt
include the planar cell polarity (PCP) and the Wnt/Ca2+ pathways. The PCP pathway is
important in gastrulation as it mediates changes in the cytoskeleton affecting cell
morphology. For PCP signaling, Wnt works through Fzd and Dvl to act on the Rho-RacJNK pathway, independent of β-catenin [12]. PCP signaling also plays a role in the
differentiation of F9 cells into PrE [38], but investigating this pathway in addition to
canonical Wnt signaling was beyond the scope of my thesis. Likewise, the third and least
understood Wnt pathway involving Wnt/Ca2+ was not investigated, and to date only one
paper has been reported to indirectly implicate the involvement of this pathway in F9 cell
differentiation [39]. Nevertheless, the fact that the Wnt/Ca2+ pathway signals through
Fzd, G-proteins, calcium/calmodulin-dependent kinase II and protein kinase C to trigger
downstream targets for cellular polarity and adhesion affecting body axis specification
during embryogenesis [40], it may be imprudent to dismiss it in having a role earlier in
mouse development. Given the three known Wnt pathways, the focus of my research was
on redox regulation pertaining only to Wnt/β-catenin signaling.
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A growing body of evidence, including some provided by this work, indicates that
Wnt/β-catenin signaling is redox regulated and that ROS play a significant role in these
early events. My study used the F9 teratocarcinoma cell line, which differentiates into
PrE upon the addition of RA, and PE following treatment with RA and db-cAMP. The
addition of RA is accompanied by increased ROS levels, which are necessary to facilitate
the differentiation to PrE [18]. Furthermore, when F9 cells are treated with RA, data
indicates that the accompanied increase in ROS signaling is necessary to regulate
components of the Wnt pathway, in particular NRX and Dvl.
Our working model proposes that in the absence of Wnt, NRX binds Dvl, thereby
preventing the latter from destabilizing the β-catenin destruction complex. RA causes
changes in gene expression, including the upregulation of Wnt6, and an increase in ROS
which results in the dissociation of Dvl from NRX. Dvl is now primed and is recruited to
the plasma membrane following binding of the Wnt ligand to its Fzd receptor and LRP5/6 co-receptor. The subsequent increase in cytoplasmic β-catenin, resulting from the
disassembly of its GSK-3β, Axin and APC destruction complex, leads to its translocation
into the nucleus where together with TCF-LEF, it can impart changes in gene expression
necessary for PrE differentiation [16, 18]. This model is of course in its simplest form and
one might question why the cell needs the negative regulation of NRX on Dvl when the
Wnt ligand is absent. Although there are many plausible explanations, the one we favour
involves a failsafe mechanism, where this negative regulation prevents aberrant activation
of the Wnt pathway in the absence of the Wnt ligand. This may also explain why the
pathway can be activated by overexpressing Dvl [31].
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4.1 Increase in ROS is necessary for ExE differentiation
RA is a morphogen that acts via nuclear receptors to exert its effects on F9 cells to
induce PrE [41]. Treatment of F9 cells with RA and db-cAMP further differentiates cells
from PrE to PE. This differentiation of F9 cells to PrE and PE is accompanied by reduced
cell proliferation, morphological changes, and transcriptional activation of several genes
including cytokeratin endo-A and tissue plasminogen activator [42]. Recently, we found
that this RA-induced differentiation to PrE in F9 cells is accompanied by an increase in
the levels of ROS. Furthermore, it was shown that RA signaling and the subsequent
increase in the levels of ROS converge on the canonical Wnt-β-catenin pathway, which
incidentally is required to induce PrE [18]. My study confirmed that RA and ROS
converge in F9 cells to induce PrE by detection of cytokeratin endo-A in RA and H2O2
treated cells. Likewise, my results corroborate those showing that TM is expressed when
RA-treated F9 cells are exposed to compounds that elevate intracellular cyclic AMP
levels indicating differentiation to PE [14]. Two very significant findings derived from
my study pertained to PE, and its ability to form in the absence of RA, when F9 cells are
either treated with H2O2 and db-cAMP or when NRX depleted F9 cells are treated with
db-cAMP. These studies highlight the importance of redox signaling in the regulation of
cellular processes associated with differentiation.
The regulation of redox signaling in cells is imperative as high ROS levels may
lead to cellular damage [21]. The importance of redox signaling with respect to
differentiation has recently attracted much attention. For instance, Yanes et al. (2010)
showed that the amounts of oxidative and reducing agents present in embryonic stem
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cells are inversely related and important in mediating embryonic cell fate [43].
Furthermore, my study has revealed that exposure to reducing agents like ascorbic acid
(Vitamin C) or NAC, significantly reduces the ability of F9 cells to differentiate in the
presence of RA, and this is consistent with the notion that signaling pathways involved in
differentiation are redox regulated. That low levels of Vitamin C (0.1 mM) were not
sufficient to significantly reduce the ability of F9 cells to differentiate in the presence of
RA may be explained by the fact that these antioxidant levels along with the increase of
ROS following RA-induction were not high enough to upset the redox regulation, and
while differentiation is hindered, it is not significantly affected. Higher concentrations of
Vitamin C (0.5 mM) and NAC (1 mM and 2 mM), however, were sufficient to overcome
the increase in ROS levels following RA treatment and therefore were able to retard
differentiation. While intracellular ROS levels were unaccounted for in this study, the
idea is consistent with previous reports indicating that the intracellular oxidation state
regulates cell differentiation [43].

4.2

Dvl and NRX are not RA responsive in F9 cells

Treatment of F9 cells with RA, and subsequent increase in ROS levels activates
Wnt signaling, specifically Wnt6 in F9 cells, causing differentiation to PrE [16]. This
increase in Wnt6 is caused by upregulation of the RA responsive genes, Gata6 and
FoxA2; Gata6 is a direct target gene of RA signaling and FoxA2 a target gene of Gata6
[12]. Wnt6 in F9 cells is necessary for PrE differentiation as the binding of Wnt to its
receptors cause Dvl to be recruited to the plasma membrane. Here, Dvl acts to inhibit the
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destruction complex allowing β-catenin to accumulate and bind to TCF-LEF in the
nucleus to activate genes necessary for PrE differentiation. Since RA causes increased
levels of Gata6 and FoxA2, which in turn activate Wnt signaling, and since Dvl is an
important regulator of the Wnt signaling pathway, I examined the possibility of Dvl
regulation by RA induction. Studies by Lee et al. (2008) on Dvl in F9 cells indicate all
three isoforms are present and show great importance in Wnt signaling as the loss of Dvl
decreases the canonical response to Wnt by impacting TCF-LEF response [34]. My study
confirms the presence of all three Dvl isoforms in F9 cells, and demonstrated that upon
RA treatment the relative levels of Dvl remain constant in comparison to vehicle treated
cells. Even though Dvl is not RA responsive, the presence of Dvl-1, Dvl-2, and Dvl-3 in
both undifferentiated and differentiated cells indicates its importance to F9 cells.
Interestingly, Funato et al. (2006) reported that Dvl binds to NRX in the Wnt/βcatenin pathway. Since NRX is a binding partner of Dvl, it was thought that if Dvl is not
regulated by RA then a possible candidate is NRX. My study is the first to look at the
role of NRX in F9 cells and its affect on differentiation to ExE. While I found that NRX
is present in F9 cells, the expression of NRX remained constant following RA treatment
compared to vehicle treated cells. While neither NRX nor Dvl show response to RA
treatment, their steady-state levels would indicate that they are regulated by other posttranslational mechanisms.
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4.3 Redox regulated interaction between NRX and Dvl-2

The results of this study clearly show that the levels of NRX and Dvl mRNA or
protein in F9 cells were not affected by RA. However, their ability to interact under
oxidizing and reducing conditions, which in the case of the former would mimic the ROS
burst that accompanies differentiation, was examined in detail. Previous reports have
shown that NRX is redox-regulated as it contains an amino acid sequence with a redox
active site, CXXC. Under oxidizing conditions, the thiol functional group on the two
cysteine residues, in the CXXC motif, form a disulfide bridge capable of changing
protein function or protein-protein interactions [27, 31]. Given this evidence, it seemed
likely that ROS would affect the redox active site on NRX in F9 cells, thereby altering its
conformation and ability to interact with other proteins [18]. Interestingly,
immunoprecipitation studies and mass spectrometry of NIH3T3 murine fibroblast cells
have been used to identify NRX as a Dvl-1 binding protein [31]. Since NRX contains a
redox active site, the authors of this study tested the effects of oxidizing and reducing
conditions on Dvl-1-NRX binding. Their data clearly show that NRX-bound Dvl-1
increases under reducing conditions, and decreases under oxidizing conditions [31],
thereby reinforcing the idea that NRX is a redox sensitive protein.
The interaction between NRX and Dvl was also shown for F9 cells in my study.
Here, the relationship between NRX and Dvl-2 was observed using coimmunoprecipitation analysis. Using this technique I was able to show that the amount of
NRX-bound to Dvl-2 increased under reducing conditions; conversely the amount of
NRX-bound to Dvl-2 decreased under oxidizing conditions.
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Given these results it seems logical to predict that the burst of ROS that occurs in
F9 cells treated with RA [18] would impact on the ability of NRX to bind Dvl-2, freeing
up the latter to transduce the Wnt signal when the ligand is present.

4.4 NRX inhibits Wnt signaling induced ExE differentiation
Given the accompanied increase in ROS levels after RA induction that activates a
canonical Wnt pathway, and that NRX and Dvl-2 show a redox dependant relationship,
the idea must be put forth that NRX is an important regulator of Wnt signaling. As
described earlier, in the presence of a canonical Wnt, Dvl is recruited to the plasma
membrane and the levels of cytoplasmic β-catenin increase by virtue of the fact that its
destruction complex (involving GSK-3β, Axin and APC) can no longer function. The βcatenin pool in the cytoplasm increases and some translocates into the nucleus where,
with TCF-LEF, the complex imparts changes to Wnt target genes. Funato et al. (2006)
examined the ability of NRX to induce activation of TCF using a luciferase reporter gene
assay. Dvl overexpression led to increased levels of TCF activity, while the expression of
TCF was completely suppressed by co-expression of NRX. Furthermore, TCF activity
was upregulated in cells expressing an NRX RNAi [31]. In F9 cells, the nuclear
accumulation of β-catenin and its interaction with TCF-LEF is obligatory for PrE
differentiation [41]. Although my study did not utilize a reporter assay, the NRX
knockdown did result in a significant increase in the level of TROMA-1 staining on
immunoblots, reminiscent of RA-induced differentiation. Taken together, this
demonstrates that the knockdown of NRX alone is sufficient to induce differentiation.
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Furthermore, knocking down NRX and increasing cAMP levels in the absence of RA, led
to a significant increase in TM, indicating the cells were competent and had differentiated
to PE. Thus given my data and the evidence from the literature, I propose that in the
absence of NRX, Dvl is not inhibited. In this free form, Dvl is thus recruited to the
plasma membrane where it serves to prevent the destruction complex from targeting βcatenin for proteasomal degradation. If this prediction is correct, then Dvl should be seen
at or near the plasma membrane; likewise, examining TOPFlash reporter activity in cells
transfected with the sh-NRX would also corroborate my prediction.

4.5 Relationship of NRX and Nox point to future research
in F9 cells
Overall, the data presented provide compelling evidence that NRX plays an
important role as a negative regulator of Wnt signaling in F9 teratocarcinoma cells. In our
model the redox regulation of NRX is imperative in controlling Wnt signaling, which
would take into account the increase in the levels of ROS following RA treatment (Fig.
4.1). In this manner, the increase in ROS is predicted to modulate the conformation of
NRX, thereby releasing Dvl and allowing it to participate in the transduction of the Wnt
signal necessary for PrE differentiation. Although it is easy to envision that NRX serves
as a failsafe mechanism to prevent aberrant Wnt signaling, the question remains as to the
source of ROS. Candidates include the Nox family of ROS producing enzymes,
consisting of Nox1-4 and Duox2, that are present in F9 cells [18]. In support of this idea
our lab has shown that RA-induced differentiation is hindered when F9 cells are treated
with the Nox inhibitor DPI [18]. This study also revealed that the Nox1–4 and Duox2
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genes are RA-responsive. Nox4 has been linked to cell proliferation, migration and stem
cell differentiation [44, 45], and that the Nox1 promoter is known to be regulated by
Gata6, a master regulator of ExE [46]. Furthermore, studies using intestinal cells showed
overexpressing NRX blocks Wnt-induced accumulation of β-catenin, however,
overexpressing NRX and coexpressing Nox1 had the reverse effect [47]. Although these
studies are encouraging and supportive, at present we do not know which of the Nox
enzymes are responsible for producing the burst of ROS that is seen in F9 cells following
exposure to RA.
Despite not knowing the source that produces the ROS in response to RA, it is
important to note that the regulation of these levels in the cell is essential since high
levels of ROS and aberrant Wnt signaling are frequently demonstrated in cancer cells
[43]. This NRX related redox regulation could have significant implications in
understanding Wnt-dependent carcinogenesis. Towards that end, this study not only
provides insight into how extraembryonic endoderm differentiates in the mammalian
embryo, but it also gives us a better understanding of the relationship between ROS and
the aberrant activation of signal transduction pathways involved in human
pathophysiology.
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Figure 4.1 A model for the differentiation of extraembryonic endoderm in F9 cells. RA
acts through binding to RA receptors and retinoid X receptors which efficiently bind RAresponse elements in the promoter regions of target genes. RA induces the expression of
Nox, leading to the production of intracellular H2O2. This increase in H2O2 levels cause
NRX to form a disulfide bridge changing conformation and causing the release of bound
Dvl-2. This in turn with binding of Wnt6 to the Fzd receptor causes Dvl-2 to be recruited
to the plasma membrane where it acts to destabilize the destruction complex causing an
increase of β-catenin in the cytosol, subsequent translocation to the nucleus where it
binds to TCF-LEF to alter gene expression necessary for differentiation to
extraembryonic endoderm.
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